Chronic migraine: risk factors, mechanisms and treatment

A May, LH Schulte - Nature Reviews Neurology, 2016 - nature.com
Chronic migraine has a great detrimental influence on a patient's life, with a severe impact
on socioeconomic functioning and quality of life. Chronic migraine affects 1–2% of the …

Pathophysiology, prevention, and treatment of medication overuse headache

HC Diener, D Dodick, S Evers, D Holle… - The Lancet …, 2019 - thelancet.com
Regular or frequent use of analgesics and acute antimigraine drugs can increase the
frequency of headache, and induce the transition from episodic to chronic headache or …

Medication-overuse headache: risk factors, pathophysiology and management

HC Diener, D Holle, K Solbach, C Gaul - Nature Reviews Neurology, 2016 - nature.com
Medication-overuse headache (MOH) is defined by the International Classification of
Headache Disorders as a headache in patients with a pre-existing primary headache …

Medication-overuse headache: a widely recognized entity amidst ongoing debate

N Vandenbussche, D Laterza, M Lisicki, J Lloyd… - The journal of headache …, 2018 - Springer
Medication overuse in primary headache disorders is a worldwide phenomenon and has a
role in the chronification of headache disorders. The burden of disease on individuals and …

Guideline on the use of onabotulinumtoxinA in chronic migraine: a consensus statement from the European Headache Federation

L Bendtsen, S Sacco, M Ashina, D Mitsikostas… - The Journal of …, 2018 - Springer
OnabotulinumtoxinA is being increasingly used in the management of chronic migraine
(CM). Treatment with onabotulinumtoxinA poses challenges compared with traditional …

Medication overuse in a subgroup analysis of phase 3 placebo-controlled studies of galcanezumab in the prevention of episodic and chronic migraine

DW Dodick, EG Doty, SK Aurora, DD Ruff… - …, 2021 - journals.sagepub.com
Introduction Acute medication overuse is prevalent in patients with migraine. Methods In
three phase 3, double-blind, randomized, placebo-controlled studies, patients with episodic …

Tension-type headache

S Ashina, DD Mitsikostas, MJ Lee, N Yamani… - Nature Reviews …, 2021 - nature.com
Tension-type headache (TTH) is the most prevalent neurological disorder worldwide and is
characterized by recurrent headaches of mild to moderate intensity, bilateral location …

European Academy of Neurology guideline on the management of medication‐overuse headache

HC Diener, F Antonaci, M Braschinsky… - European journal of …, 2020 - Wiley Online Library
Background The frequent use of medication to treat migraine attacks can lead to an increase
in migraine frequency and is called medication‐overuse headache (MOH). Methods Based …

Rethinking headache as a global public health case model for reaching the SDG 3 HEALTH by 2030

P Martelletti, M Leonardi, M Ashina, R Burstein… - The Journal of …, 2023 - Springer
Abstract The 2030 Agenda for Sustainable Development sets out, through 17 Sustainable
Development Goals (SDGs), a path for the prosperity of people and the planet. SDG 3 in …

Patient-centered treatment of chronic migraine with medication overuse: a prospective, randomized, pragmatic clinical trial

TJ Schwedt, JG Hentz, S Sahai-Srivastava… - Neurology, 2022 - AAN Enterprises
Background and Objectives Overuse of symptomatic (ie, acute) medications is common
among those with chronic migraine. It is associated with developing frequent headaches …